Eli Lilly Strikes Up to $2.75 Billion AI Drug Deal With Insilico Medicine
By
Emma Clarke
Eli Lilly will pay up to $2.75 billion to bring AI-developed drugs from Insilico Medicine to market. The deal highlights growing momentum in AI-driven drug discovery.